AUSTRALIAN, January 21, 2020 (HEMPGAZETTE) There’s a lot of activity on the Australian cannabusiness scene, but what is happening at the patient end of things? Statistics from the Therapeutic Goods Administration (TGA) indicate significant growth in approvals, but it wouldn’t even be touching the sides of potential...
U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
CANADA, October 2 2019 (ANALYTICALCANNABIS) Researchers at Western University, Canada, have uncovered the exact molecular mechanisms that cause CBD to block some of the negative psychiatric side effects associated with high levels of THC in cannabis.
Their study, the results of which were recently published in the Journal of Neuroscience, identified extracellular-signal regulated...
U.S, January 29, 2020 (ANALYTICALCANNABIS) Several recent studies have suggested that CBD has an antipsychotic effect in people with existing forms of psychosis. But just how the cannabis compound is achieving this effect has remained unclear. Now, researchers from King’s College London say they may know the answer....
U.S, MARIJUANA BUSINESS DAILY (20 June 21) Recreational marijuana makes the most headlines, but a large number of cannabis consumers buy and use the plant for medical and wellness reasons.
These include acute medical conditions such as cancer, chronic pain and epilepsy, as well...
U.S, November 16, 2019 (CANNABISNOW) Henep CBD products are manufactured with bioavailability as a focus for individuals that lead active lifestyles.
From edibles to vapes, hemp extracts and smokable hemp flower, the market is flooded with CBD products in multiple available consumption options.
Cannabinoids like CBD are lipophilic molecules, meaning that...